Advertisement

Topics

Search Results for "Is Metformin Hydrochloride The Same As Metformin"

14:25 EDT 28th May 2017 | BioPortfolio

Matching Channels

None

Matching News

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin / metformin, Revision: 15, Authorised

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin / metformin, Revision: 14, Authorised

Eli Lilly Release: U.S. FDA Approves Supplemental New Drug Applications To Include Landmark Data In Product Labels For Synjardy (Empagliflozin/Metformin Hydrochloride), Synjardy XR (Empagliflozin/Metformin Hydrochloride Extended-Release) And Glyxambi (Emp

  Life Sciences Jobs   ...

BRIEF-U.S. FDA approves supplemental New Drug Applications for three Type 2 diabetes medicines

* U.S. FDA approves supplemental new drug applications to include landmark data in product labels for synjardy (empagliflozin/metformin hydrochloride), synjardy xr (empagliflozin/metformin hydrochlori...

U.S. FDA approves supplemental New Drug Applications to include landmark data in product labels for Synjardy® (empagliflozin/metformin hydrochloride), Synjardy® XR (empagliflozin/metformin hydrochloride extended-release) and Glyxambi® (empagliflozin/li

U.S. FDA approves supplemental New Drug Applications to include landmark data in product labels for Synjardy® (empagliflozin/metformin hydrochloride), Synjardy® XR (empagliflozin/metformin h...

Metformin use linked to less vitamin B12 measurement

(HealthDay)—Long-term metformin use is associated with lower serum vitamin B12 concentration, although metformin users are less likely to receive vitamin B12 testing, according to a study published ...

Intellipharmaceutics’ diabetes generic drug scores FDA approval

TORONTO, ON-The FDA has given Toronto-based Intellipharmaceutics International approval for its generic version of Bristol-Myers Squibb’s Glucophage XR, or metformin hydrochloride, for patients ...

Metformin may reduce mortality in patients with certain chronic diseases

Recent changes in metformin labeling by the FDA is supported by new findings published in Annals of Internal Medicine that suggest that patients with chronic kidney disease, congestive heart failure a...

Matching PubMed Articles

Understanding and overcoming metformin gastrointestinal intolerance.

Metformin is the most widely prescribed drug for patients with type 2 diabetes mellitus and the first-line pharmacologic option as supported by multiple international guidelines, yet a rather large pr...

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.

Metformin is widely used in the treatment of type 2 diabetes (T2D), but its mechanism of action is poorly defined. Recent evidence implicates the gut microbiota as a site of metformin action. In a dou...

Trends in metformin utilisation and dose appropriateness in Australia.

The study aimed to (1) determine the trends in the utilisation of metformin in Australia, (2) determine the appropriateness of metformin dosing in an Australian teaching hospital and (3) gather the op...

The Influence of Chitosan Cross-linking on the Properties of Alginate Microparticles with Metformin Hydrochloride-In Vitro and In Vivo Evaluation.

Sodium alginate is a polymer with unique ability to gel with different cross-linking agents in result of ionic and electrostatic interactions. Chitosan cross-linked alginate provides improvement of sw...

Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells.

Metformin is most widely prescribed for type 2 diabetes. Recently, evidences have shown that metformin has anticancer effects on pancreatic-, colorectal-, ovarian-, and other cancers. Because metformi...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement